Owlstone Medical wins £36m award from US Gov ARPA-H programme to develop at-home cancer detection tests

Owlstone Medical develops breath-based diagnostic technologies that detect disease using chemical markers, enabling non-invasive screening and monitoring for cancer and chronic conditions at home or point of care.